Number of Shares
159,034.00
Current Holdings Value*
CHF17.69 Mil
% of Portfolio
1.27%
Total Estimate Gain
CHF1.14 Mil
% of Total Estimate Gain
5.60%

MetLife MSCI EAFE Index Portfolio's Novartis AG Holding Summary

As of 2025-03-31, Brighthouse Funds Trust II held 159,034.00 shares of Novartis AG(XSWX:NOVN), totaling CHF17.69 Mil. This investment constitutes 1.27% of their stock portfolio, and Brighthouse Funds Trust II now holds 0.01% of the outstanding Novartis AG(XSWX:NOVN) stock.

The initial trade took place in 2019Q3. And since then MetLife MSCI EAFE Index Portfolio has made 3 purchases of XSWX:NOVN, at an average price of CHF89.42, for a total of 226,907.00 shares. In addition, there have been 12 sales at an average price of CHF85.77 for 67,873.00 shares. Based on historical transaction data and XSWX:NOVN's current price of CHF98.12, MetLife MSCI EAFE Index Portfolio's estimated gain on his XSWX:NOVN holdings is CHF1.14 Mil, reflecting a 5.60% gain to date.

MetLife MSCI EAFE Index Portfolio XSWX:NOVN (CHF98.12) Holding Chart

MetLife MSCI EAFE Index Portfolio XSWX:NOVN (CHF98.12) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price CHF-/Share
Shares Sold 0 Average Price CHF-/Share
Current Price CHF0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1